CA2387808A1 - Chimiokine beta 13 humaine - Google Patents
Chimiokine beta 13 humaine Download PDFInfo
- Publication number
- CA2387808A1 CA2387808A1 CA002387808A CA2387808A CA2387808A1 CA 2387808 A1 CA2387808 A1 CA 2387808A1 CA 002387808 A CA002387808 A CA 002387808A CA 2387808 A CA2387808 A CA 2387808A CA 2387808 A1 CA2387808 A1 CA 2387808A1
- Authority
- CA
- Canada
- Prior art keywords
- polypeptide
- amino acid
- seq
- beta
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne une nouvelle protéine CK.beta.-13 faisant partie de la famille des chimiokines. Elle porte notamment sur des molécules d'acide nucléique isolées codant pour la protéine CK.beta.-13 humaine. Des polypeptides CK.beta.-13 sont également décrits ainsi que des vecteurs, des cellules hôtes et des méthodes de recombinaison pour la production de ceux-ci. L'invention se rapporte encore à des méthodes de criblage permettant l'identification d'agonistes et d'antagonistes de l'activité de CK.beta.-13 ainsi qu'à des méthodes diagnostiques pour la détection de troubles liés au système immunitaire, et à des méthodes thérapeutiques pour le traitement de troubles relatifs au système immunitaire.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43276899A | 1999-11-03 | 1999-11-03 | |
US09/432,768 | 1999-11-03 | ||
PCT/US2000/030237 WO2001032128A2 (fr) | 1999-11-03 | 2000-11-02 | Chimiokine beta 13 humaine |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2387808A1 true CA2387808A1 (fr) | 2001-05-10 |
Family
ID=23717510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002387808A Abandoned CA2387808A1 (fr) | 1999-11-03 | 2000-11-02 | Chimiokine beta 13 humaine |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1229795A4 (fr) |
JP (1) | JP2003514517A (fr) |
AU (1) | AU1581301A (fr) |
CA (1) | CA2387808A1 (fr) |
WO (1) | WO2001032128A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6737513B1 (en) | 1996-06-07 | 2004-05-18 | Icos Corporation | Macrophage derived chemokine (MDC) and chemokine analogs and assay to identify modulators of MDC activity, and therapeutic uses for same |
US7018627B1 (en) | 1995-06-07 | 2006-03-28 | Icos Corporation | Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof |
US20060228331A1 (en) | 2003-10-10 | 2006-10-12 | Novo Nordisk A/S | IL-21 Derivatives and variants |
CA2542662A1 (fr) * | 2003-10-17 | 2005-04-28 | Novo Nordisk A/S | Combinaisons pharmaceutiques comprenant de l'il-21 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9708528A (es) * | 1995-06-06 | 1998-02-28 | Human Genome Sciences Inc | Quimiosina bata-13 humana. |
DE69631971D1 (de) * | 1995-11-30 | 2004-04-29 | Us Government | C-c chemokine die die infektion mit retoviren verhindern |
CA2277580A1 (fr) * | 1996-12-05 | 1998-06-11 | Human Genome Sciences, Inc. | Chimiokine beta-13 d'origine humaine |
-
2000
- 2000-11-02 EP EP00978340A patent/EP1229795A4/fr not_active Withdrawn
- 2000-11-02 CA CA002387808A patent/CA2387808A1/fr not_active Abandoned
- 2000-11-02 WO PCT/US2000/030237 patent/WO2001032128A2/fr not_active Application Discontinuation
- 2000-11-02 JP JP2001534336A patent/JP2003514517A/ja not_active Withdrawn
- 2000-11-02 AU AU15813/01A patent/AU1581301A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1229795A2 (fr) | 2002-08-14 |
WO2001032128A3 (fr) | 2001-11-08 |
JP2003514517A (ja) | 2003-04-22 |
WO2001032128A9 (fr) | 2002-05-16 |
AU1581301A (en) | 2001-05-14 |
WO2001032128A2 (fr) | 2001-05-10 |
EP1229795A4 (fr) | 2004-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6593112B1 (en) | Polynucleotides encoding fibroblast growth factor 15 | |
US6605699B1 (en) | Galectin-11 polypeptides | |
US6472512B1 (en) | Keratinocyte derived interferon | |
US20020193305A1 (en) | Cytokine receptor common gamma chain like | |
US20030186387A1 (en) | Interleukins-21 and 22 | |
CA2323776C (fr) | Analogue de chaine gamma commune de recepteur de cytokine | |
US20030186308A1 (en) | Prostacyclin-stimulating factor-2 | |
US20030180892A1 (en) | Interleukin-20 | |
US6605441B1 (en) | Antibodies against fibroblast growth factor 11 | |
US6982320B2 (en) | Cytokine receptor common gamma chain like | |
US20030180891A1 (en) | Connective tissue growth factor-4 | |
US20030022327A1 (en) | Dendritic enriched secreted lymphocyte activation molecule | |
CA2387808A1 (fr) | Chimiokine beta 13 humaine | |
US20030022277A1 (en) | Human neuropeptide receptor | |
US20040225118A1 (en) | 31 human secreted proteins | |
US20030204065A1 (en) | PGRP-L polynucleotides, polypeptides, and antibodies | |
US6534485B1 (en) | Bone marrow-specific protein | |
US20020025553A1 (en) | Transforming growth factor alpha HIII | |
US20020055147A1 (en) | Human chemokine beta-13 | |
US6620912B2 (en) | Dendritic enriched secreted lymphocyte activation molecule | |
CA2347080A1 (fr) | Gene 12 lie au recepteur de tnf (tnfr) | |
US20020026037A1 (en) | Vascular endothelial growth factor 3 antibodies | |
US6365369B1 (en) | Prostate specific secreted protein | |
US6936688B2 (en) | Human chemokine beta-10 mutant polypeptides | |
US20050026838A1 (en) | Fibroblast Growth Factor-13 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |